Company Directory / research

PrivateFor profitresearchLeiden, Netherlands
Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies.
Size
11-50 people: larger than 33% of companies with a size listed
Age
7 years old.
Reach
Website ranked #7,820,318 in the world for traffic, about 701 visits a month.
Health CareMedicalPharmaceutical
Funding, as listed
$115M currency not stated
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about Vico Therapeutics, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
About this record
Growth, as the source summarises it
Vico Therapeutics received complementary Series B funding totaling €65.8 million ($70.7 million) from Seroba and Kurma Partners. Additionally, Vico Therapeutics raised EUR11.5M in additional Series B funding.
Summaries written by the source dataset, not by us, and not checked.
research in Netherlands.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 174,966 companies in Netherlands and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.